Table 4.
Optimal flow of Midazolam to pharmacies (t = 1, 2, 3)
Brand | Pharmacy | No competition | Competitive market | ||||
---|---|---|---|---|---|---|---|
Product flow in each period | Product flow in each period | ||||||
1 | 2 | 3 | 1 | 2 | 3 | ||
Actoverco | 1 | 660 | 1100 | – | 965 | 1525 | – |
2 | 725 | 1150 | – | 955 | 1440 | – | |
3 | 1155 | 1510 | – | 1155 | 1510 | – | |
4 | 445 | 895 | 450 | 250 | 747 | 250 | |
5 | 379 | 695 | 455 | 116 | 303 | 200 | |
6 | 395 | 800 | 390 | 342 | 685 | 342 | |
7 | 385 | 850 | 360 | 510 | 1170 | 505 | |
Abidi | 1 | 665 | 1110 | – | 360 | 685 | – |
2 | 725 | 1140 | – | 495 | 850 | – | |
3 | 1155 | 1500 | – | 1155 | 1500 | – | |
4 | 445 | 895 | 450 | 640 | 1042 | 650 | |
5 | 380 | 695 | 460 | 642 | 1085 | 715 | |
6 | 400 | 795 | 400 | 456 | 914 | 456 | |
7 | 385 | 750 | 370 | 260 | 430 | 225 |